Alize launched the €3.9 million ($5.1 million) PREMAG collaborative research program to develop Alize's AZP-531.The group will develop the unacylated ghrelin analog for indications including cardiovascular complications of diabetes, cardioprotection following ischemia-reperfusion and cachexia associated...

Bertin's Spi-BIO subsidiary will exclusively distribute Aterovax's sPLA2 test for research use in Europe for three years. The test for secretory phospholipase A2 ( PLA2G2A ; sPLA2) activity in blood plasma is in pivotal testing...